Persistent Corneal Epithelial Defect Following Pars Plana Vitrectomy: A Narrative Review.
Ziafati M, Mirshahi R, Cicinelli MV, Nazari R.
Semin Ophthalmol. 2025 Nov;40(8):743-755. doi: 10.1080/08820538.2025.2470253. Epub 2025 Feb 24.
Persistent Epithelial Defect.
Golhait P, Peseyie R.
2023 Jul 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Neurotrophic keratopathy: current challenges and future prospects.
NaPier E, Camacho M, McDevitt TF, Sweeney AR.
Ann Med. 2022 Dec;54(1):666-673. doi: 10.1080/07853890.2022.2045035.
Cenegermin (Oxervate): CADTH Reimbursement Recommendation: Indication: For the treatment of moderate (persistent epithelial defect) or severe (corneal ulcer) neurotrophic keratitis in adults.
[No authors listed]
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jul.
Autologous serum eye drops in dry eye disease: Preferred practice pattern guidelines.
Vazirani J, Sridhar U, Gokhale N, Doddigarla VR, Sharma S, Basu S.
Indian J Ophthalmol. 2023 Apr;71(4):1357-1363. doi: 10.4103/IJO.IJO_2756_22.
Topical insulin for refractory persistent corneal epithelial defects.
Abdi P, Ghaffari R, Azad N, Alshaheeb A, Latifi G, Soltani Shahgoli S, Fakhredin H.
Sci Rep. 2024 May 30;14(1):12459. doi: 10.1038/s41598-024-63091-y.
PERSISTENT CORNEAL EPITHELIAL DEFECT AFTER PARS PLANA VITRECTOMY.
Chen HF, Yeung L, Yang KJ, Sun CC.
Retina. 2016 Jan;36(1):148-55. doi: 10.1097/IAE.0000000000000657.
The role of topical insulin in ocular surface restoration: A review.
Krolo I, Behaegel J, Termote K, de Bruyn B, De Schepper M, Oellerich S, Ní Dhubhghaill S.
Surv Ophthalmol. 2024 Sep-Oct;69(5):805-817. doi: 10.1016/j.survophthal.2024.04.003. Epub 2024 Apr 10.
Effectiveness of topical insulin for the treatment of surface corneal pathologies.
Castro Mora MP, Palacio Varona J, Perez Riaño B, Laverde Cubides C, Rey-Rodriguez DV.
Arch Soc Esp Oftalmol (Engl Ed). 2023 Apr;98(4):220-232. doi: 10.1016/j.oftale.2023.03.007. Epub 2023 Mar 5.
Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea.
Diaz-Valle D, Burgos-Blasco B, Rego-Lorca D, Puebla-Garcia V, Perez-Garcia P, Benitez-Del-Castillo JM, Herrero-Vanrell R, Vicario-de-la-Torre M, Gegundez-Fernandez JA.
Acta Ophthalmol. 2022 Jun;100(4):e912-e919. doi: 10.1111/aos.14997. Epub 2021 Aug 18.
